This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Park, S. S. Articles by Janz, S. Search for Related Content PubMed PubMed Citation Articles by Park, S. S. Articles by Janz, S.

Insertion of c-Myc into Igh Induces B-Cell and Plasma-Cell Neoplasms in Mice

¹ Laboratory of Genetics, ² Genetics Branch, Center for Cancer Research, National Cancer Institute, and ³ Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland; ⁴ Laboratory for Neural Development, Center for Cancer Research, National Cancer Institute, Frederick, Maryland; and ⁵ Cell Signaling Technology, Beverly, Massachusetts

Requests for reprints: Siegfried Janz, Laboratory of Genetics, Center for Cancer Research, National Cancer Institute, Building 37, Room 3140A, Bethesda, MD 20892-4256. Phone: 301-496-2202; Fax: 301-402-1031; E-mail: sj4s{at}nih.gov.

We used gene targeting in mice to insert a His₆-tagged mouse c-Myc cDNA, Myc^His, head to head into the mouse immunoglobulin heavy-chain locus, Igh, just 5' of the intronic enhancer, Eµ. The insertion of Myc^His mimicked both the human t(8;14)(q24;q32) translocation that results in the activation of MYC in human endemic Burkitt lymphomas and the homologous mouse T(12;15) translocation that deregulates Myc in certain mouse plasmacytomas. Beginning at the age of 6 months, Myc^His transgenic mice developed B-cell and plasma neoplasms, such as IgM⁺ lymphoblastic B-cell lymphomas, Bcl-6⁺ diffuse large B-cell lymphomas, and CD138⁺ plasmacytomas, with an overall incidence of 68% by 21 months. Molecular studies of lymphoblastic B-cell lymphoma, the most prevalent neoplasm (50% of all tumors), showed that the lymphomas were clonal, overexpressed Myc^His, and exhibited the P2 to P1 promoter shift in Myc expression, a hallmark of MYC/Myc deregulation in human endemic Burkitt lymphoma and mouse plasmacytoma. Only 1 (6.3%) of 16 lymphoblastic B-cell lymphomas contained a BL-typical point mutation in the amino-terminal transactivation domain of Myc^His, suggesting that most of these tumors are derived from naive, pregerminal center B cells. Twelve (46%) of 26 lymphoblastic B-cell lymphomas exhibited changes in the p19^Arf-Mdm2-p53 tumor suppressor axis, an important pathway for Myc-dependent apoptosis. We conclude that Myc^His insertion into Igh predictably induces B-cell and plasma-cell tumors in mice, providing a valuable mouse model for understanding the transformation-inducing consequences of the MYC/Myc-activating endemic Burkitt lymphoma t(8;14)/plasmacytoma T(12;15) translocation.

Key Words: Chromosomal translocations activating human c-MYC or mouse c-Myc • human t(8;14)(q24;q32) and mouse T(12;15) translocations • human Burkitt's lymphoma and mouse plasmacytoma • gene targeting in mice

This article has been cited by other articles:

				G Brady, G J MacArthur, and P J Farrell Epstein-Barr virus and Burkitt lymphoma Postgrad. Med. J., July 1, 2008; 84(993): 372 - 377. [Abstract] [Full Text] [PDF]

				G Brady, G J MacArthur, and P J Farrell Epstein Barr virus and Burkitt lymphoma J. Clin. Pathol., December 1, 2007; 60(12): 1397 - 1402. [Abstract] [Full Text] [PDF]

				V. Truffinet, E. Pinaud, N. Cogne, B. Petit, L. Guglielmi, M. Cogne, and Y. Denizot The 3' IgH Locus Control Region Is Sufficient to Deregulate a c-myc Transgene and Promote Mature B Cell Malignancies with a Predominant Burkitt-Like Phenotype J. Immunol., November 1, 2007; 179(9): 6033 - 6042. [Abstract] [Full Text] [PDF]

				B. Zhang, A. Alaie-Petrillo, M. Kon, F. Li, and L. A. Eckhardt Transcription of a Productively Rearranged Ig VDJC{alpha} Does Not Require the Presence of HS4 in the Igh 3' Regulatory Region J. Immunol., May 15, 2007; 178(10): 6297 - 6306. [Abstract] [Full Text] [PDF]

				C.-F. Qi, J. X. Zhou, C. H. Lee, Z. Naghashfar, S. Xiang, A. L. Kovalchuk, T. N. Fredrickson, J. W. Hartley, D. C. Roopenian, W. F. Davidson, et al. Anaplastic, Plasmablastic, and Plasmacytic Plasmacytomas of Mice: Relationships to Human Plasma Cell Neoplasms and Late-Stage Differentiation of Normal B Cells Cancer Res., March 15, 2007; 67(6): 2439 - 2447. [Abstract] [Full Text] [PDF]

				S. S. Park, A. L. Shaffer, J. S. Kim, W. duBois, M. Potter, L. M. Staudt, and S. Janz Insertion of Myc into Igh Accelerates Peritoneal Plasmacytomas in Mice Cancer Res., September 1, 2005; 65(17): 7644 - 7652. [Abstract] [Full Text] [PDF]